The GLP is committed to full transparency. Download and review our 2019 Annual Report

Personal genomics: New drugs target common cancers

| September 10, 2012
Tens of thousands of Americans with tumors from certain types of lung cancer have mutations that might be treated by new drugs that are already in the pipeline or that could be easily developed–a dramatic demonstration of the promise of personalized genomic-based medicine.
Additional Resources:

The GLP featured this article to reflect the diversity of news, opinion and analysis. The viewpoint is the author’s own. The GLP’s goal is to stimulate constructive discourse on challenging science issues.

News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.

Send this to a friend